1. Home
  2. RILYP vs SCLXW Comparison

RILYP vs SCLXW Comparison

Compare RILYP & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RILYP

B. Riley Financial Inc.

N/A

Current Price

$13.18

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Logo Scilex Holding Company

SCLXW

Scilex Holding Company

N/A

Current Price

$0.18

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RILYP
SCLXW
Founded
1973
N/A
Country
United States
United States
Employees
1380
34
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RILYP
SCLXW
Price
$13.18
$0.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.6K
6.0K
Earning Date
01-01-0001
03-07-2025
Dividend Yield
7.03%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$854,383,000.00
$55,152,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
22.02
52 Week Low
$3.25
$0.05
52 Week High
$17.52
$0.64

Technical Indicators

Market Signals
Indicator
RILYP
SCLXW
Relative Strength Index (RSI) 28.56 49.27
Support Level $8.35 $0.17
Resistance Level $14.50 $0.21
Average True Range (ATR) 0.29 0.02
MACD -0.05 -0.00
Stochastic Oscillator 0.72 60.03

Price Performance

Historical Comparison
RILYP
SCLXW

About RILYP B. Riley Financial Inc.

BRC Group Holdings Inc is a diversified holding company offering a platform of businesses, including financial services, telecom, retail, and investments in equity, debt, and venture capital. It serves retail, corporate, capital providers, and individual customers across various business lines. The Group has seven reportable business segments: Capital Markets, Wealth Management, Lingo, magicJack, Marconi Wireless, UOL, and Consumer Products. Maximum revenue is generated from the Capital Markets segment, which provides investment banking and institutional brokerage services, offers loans, trades in equity securities, and maintains an investment portfolio of public and private equities and debt securities. Geographically, the Group derives maximum revenue from its business in North America.

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: